RT Book, Section
A1 Beauduy, Camille E.
A1 Winston, Lisa G.
A2 Katzung, Bertram G.
SR Print(0)
ID 1148440075
T1 Tetracyclines, Macrolides, Clindamycin, Chloramphenicol, Streptogramins, & Oxazolidinones
T2 Basic & Clinical Pharmacology, 14e
YR 2017
FD 2017
PB McGraw-Hill Education
PP New York, NY
SN 9781259641152
LK accessmedicine.mhmedical.com/content.aspx?aid=1148440075
RD 2024/04/19
AB CASE  STUDYA  22-year-old  woman  presents  to  her  college  medical  clinic  complaining  of  a  2-week  history  of  vaginal  discharge.  She  denies  any  fever  or  abdominal  pain  but  does  report  vaginal  bleeding  after  sexual  intercourse.  When  questioned  about  her  sexual  activity,  she  reports  having  vaginal  intercourse,  at  times  unprotected,  with  two  men  in  the  last  6  months.  A  pelvic  examination  is  performed  and  is  positive  for  mucopurulent  discharge  from  the  endocervical  canal.  No  cervical  motion  tenderness  is  present.  A  first-catch  urine  specimen  is  obtained  for  chlamydia  and  gonorrhea  nucleic  acid  amplification  testing.  A  urine  pregnancy  test  is  also  ordered  as  the  patient  reports  she  “missed  her  last  period.”  Pending  these  results,  the  decision  is  made  to  treat  her  presumptively  for  chlamydial  cervicitis.  What  are  two  potential  treatment  options  for  her  possible  chlamydial  infection?  How  does  her  potential  pregnancy  affect  the  treatment  decision?